Gene · 1847
DUSP5: dual specificity phosphatase 5
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. DUSP5: dual specificity phosphatase 5. Genes, record 1847. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/1847
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q16690 | Dual specificity protein phosphatase 5 | 384 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents28
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4831300 A1 | 2026-10-28 | 88 | Q16690 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 44342 | Q16690 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 8646 | Q16690 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 8817 | Q16690 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 5462 | Q16690 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 8817 | Q16690 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 8646 | Q16690 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 27552 | Q16690 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 5462 | Q16690 | Espacenet |
| EP 4461818 A2 | 2024-11-13 | 27552 | Q16690 | Espacenet |
1 to 10 of 28
See all 28 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,226
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | DUSP5 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 12 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 10 | 2025 |
| U19AI057266 | Vaccine and Infection Induced Immunity in the Young and Aged | 7 | 2025 |
| P30CA046934 | University of Colorado Cancer Center Support Grant | 5 | 2025 |
| P30CA033572 | Cancer Center Support Grant | 4 | 2025 |
| P30CA045508 | CSHL Cancer Center Support Grant | 4 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 4 | 2025 |
| R01HL117913 | The NOTCH Signaling Pathway in Large Vessel Vasculitis | 4 | 2025 |
| P01CA163222 | Targetable epigenetic and transcriptional mechanisms in melanoma thatshape the microenvironment | 3 | 2025 |
| P30CA076292 | Moffitt Cancer Center Support Grant | 3 | 2025 |
1 to 10 of 1,226Source NIH's project files
See all 1,226 nih grantsPapers1,652
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular predictors of recurrence in vestibular schwannomas: a transcriptomic and RT-qPCR analysis. | Eur Arch Otorhinolaryngol | 2026 | 42642532 | PubTator, text mining | PubMed |
| Development of receptor and oncogene-responsive luciferase reporter vectors that are activated via kinase signaling to AP-1. | Exp Hematol | 2026 | 42595074 | PubTator, text mining | PubMed |
| DUSP5 contributes to platinum resistance in ovarian cancer: single-cell discovery and functional validation. | Front Pharmacol | 2026 | 42564493 | PubTator, text mining | PubMed |
| Executive Function and Epigenetic Markers in Youth Exposed to Family and Community Violence in Childhood. | Dev Psychobiol | 2026 | 42543904 | PubTator, text mining | PubMed |
| CRISPR screens identify targets to rescue age-related T cell dysfunction in cancer. | Cell | 2026 | 42526438 | PubTator, text mining | PubMed |
| The dual specificity phosphatase 2 act as distal regulatory node in T cell signaling. | iScience | 2026 | 42519028 | PubTator, text mining | PubMed |
| p53 and p21 Status Influences Cellular Response to Metformin in KRAS-Mutant HCT116 Colorectal Cancer Cells. | Curr Issues Mol Biol | 2026 | 42510971 | PubTator, text mining | PubMed |
| DUSP5 regulates ferroptosis in pancreatic cancer by down-regulating SCD1 expression via ERK1/2. | Acta Biochim Biophys Sin (Shanghai) | 2026 | 42473698 | PubTator, text mining | PubMed |
| Structural and biochemical analyses of a novel bacterial dual specificity phosphatase from Candidatus Chlorohelix allophototropha. | J Microbiol | 2026 | 42457432 | PubTator, text mining | PubMed |
| Crosstalk Between Immunometabolic Pathways in Non-Small Cell Lung Cancer. | Immunol Invest | 2026 | 42427023 | PubTator, text mining | PubMed |
1 to 10 of 1,652
See all 1,652 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/1847
GET https://conductscience.org/api/genes/v1/1847/patents?page=2